SEC Insider Transactions from Olinger Margaret.

Last updated: 2026-03-14 11:23 UTC | Total transactions: 9

Olinger Margaret has filed 9 insider transactions across 1 company since January 2023.

Most recent transaction: a option exercise of 25000 shares of Amylyx Pharmaceuticals, Inc. ($AMLX) on December 27, 2023.

Activity breakdown: 0 open-market purchases and 2 sales.

Set Up your own filters →
Transaction Date Company Ticker Insider Name Title Transaction Type Security Shares Price Shares Owned Following Total Shares Outstanding % of Owned % of Outstanding
Dec. 27, 2023 Amylyx Pharmaceuticals, Inc. $AMLX Olinger Margaret Chief Commercial Officer M Common Stock 25000 $0.37 276,108.0000 0 9.96% 0.00%
Dec. 27, 2023 Amylyx Pharmaceuticals, Inc. $AMLX Olinger Margaret Chief Commercial Officer M Stock Option (Right to Buy) 25000 $0.00 44,577.0000 0 35.93% 0.00%
July 12, 2023 Amylyx Pharmaceuticals, Inc. $AMLX Olinger Margaret Chief Commercial Officer M Common Stock 20000 $0.37 251,108.0000 0 8.65% 0.00%
July 12, 2023 Amylyx Pharmaceuticals, Inc. $AMLX Olinger Margaret Chief Commercial Officer M Stock Option (Right to Buy) 20000 $0.00 69,577.0000 0 22.33% 0.00%
May 22, 2023 Amylyx Pharmaceuticals, Inc. $AMLX Olinger Margaret Chief Commercial Officer G Common Stock 1580 $0.00 231,108.0000 0 0.68% 0.00%
March 16, 2023 Amylyx Pharmaceuticals, Inc. $AMLX Olinger Margaret Chief Commercial Officer A Common Stock 18333 $0.00 232,688.0000 0 8.55% 0.00%
March 16, 2023 Amylyx Pharmaceuticals, Inc. $AMLX Olinger Margaret Chief Commercial Officer A Stock Option (right to buy) 82500 $0.00 82,500.0000 0 9999.99% 0.00%
Jan. 6, 2023 Amylyx Pharmaceuticals, Inc. $AMLX Olinger Margaret Chief Commercial Officer S Common Stock 1660 $36.08 215,098.0000 0 0.78% 0.00%
Jan. 6, 2023 Amylyx Pharmaceuticals, Inc. $AMLX Olinger Margaret Chief Commercial Officer S Common Stock 743 $36.79 214,355.0000 0 0.35% 0.00%